Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_assertion type Assertion NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_head.
- NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_assertion wasGeneratedBy ECO_0000203 NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_provenance.
- NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_assertion wasDerivedFrom befree-2016 NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_provenance.
- NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_assertion SIO_000772 22547605 NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_provenance.
- NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_assertion evidence source_evidence_literature NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_provenance.
- NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_assertion description "[Erlotinib is clinically effective in patients with non-small-cell lung cancer (NSCLC) who have adenocarcinoma, are never or limited former smokers, or have EGFR mutant tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978720.RASq0LuYlCmtxTlR2shQovwpc5IQxGsU7LxTuXLniLTkA130_provenance.